Axsome Therapeutics Inc Solriamfetol Investor Day Transcript
Good morning and welcome to the Axsome Therapeutics conference call. Currently, all participants are in a listen only mode. Later there will be a question-and -answer session. As a reminder, today's conference is being recorded.
I would now like to turn the conference over to Darren Opland, Director, Corporate Communications at Axsome Therapeutics. Thank you. Please go ahead.
Good morning, and thank you all for joining us for today's Solriamfetol Investor Event Conference Call. During today's call, we will be making certain forward looking statements. These statements may include statements regarding, among other things, the efficacy, safety and intended utilization of our investigational agents, our clinical and nonclinical plans, our plans to present oor report additional data, the anticipated conduct and the source of future clinical trials regulatory plans, future research and development plans, our commercial plans regarding Sunosi ability and our pipeline products,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |